Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™
-
Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™
-
RYVYL Executes Strategic Actions Enhancing Its Business Plan and Files S-1 Registration Statement
-
RYVYL Appoints Industry Veteran Brett Moyer to Its Board of Directors
-
NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
-
Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate for Stargardt Di
-
Mark Ford Joins Highway as Chief Capacity Officer
-
OTC Markets Group Welcomes Southpoint Bancshares Inc. to OTCQX
-
Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 85th Scientific Sessions
-
Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio
-
Fury Finalizes Drill Targeting at its Newly Acquired Sakami Gold Project
-
Giyani Receives Letter of Interest from EXIM for US$225 million
-
Mirasol Signs MOU for the Sale of the Virginia Silver Project and Landholdings in Argentina for US$8 Million Plus 2% NSR Royalty
-
Guardian Capital Announces June 2025 Cash Distributions for Guardian Capital ETFs
-
Abcourt Intersects 4.1 g/t Gold over 11 Metres in Channel on the Former Cambior Stripping, extends the mineralized zone over a length of now 300m in the Cartwright Area of the Flordin Project, and Pre
-
Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway
-
Anfield Files Notice of Intent to Conduct Drill Program As It Expands Its Hub-And-Spoke Uranium and Vanadium Production Model
-
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025
-
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Second Quarter of 2025
-
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025
-
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
THCA Flower 2025: NexZen Extracts Unveils 2025 THCA Flower Lineup Featuring Godfather OG, Sex Panther, and Gelato
-
Delta 8 Gummies 2025: NexZen Extracts Sets the Standard for Flavor, Potency, and Quality
-
Presenting on Emerging Growth Conference 83 Day 1 on June 17; Register to live stream
-
BioCryst Presents New Data on the Long-term Efficacy and Safety of ORLADEYO® (berotralstat) Across all Ages at EAACI
-
Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million
-
iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment
-
Portillo’s Adds Veteran Restaurant Leader Gene Lee to Board of Directors
-
USA Rare Earth and Moog Sign Memorandum of Understanding for Delivery of U.S.-Made Neo Magnets for Data Center Cooling Solutions
-
Axsome Therapeutics Proudly Supports Migraine and Headache Awareness Month Alongside the Association of Migraine Disorders
-
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions
-
ORIGENCE ENHANCES ARC OS PLATFORM UNDERWRITING WITH EXPERIAN'S POWERCURVE DECISIONING INTEGRATION
-
Coda Octopus Group Reports Fiscal Second Quarter 2025 Financial Results
-
Mavenir Signs Debt Recapitalization Transaction to Drive Continued Growth
-
Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device
-
Pulmovant Announces Publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics
-
ORIGENCE ENHANCES ARC OS PLATFORM UNDERWRITING WITH EXPERIAN'S POWERCURVE DECISIONING INTEGRATION
-
Nokia announces changes to Group Leadership Team
-
Signify share repurchase period update
-
Pharvaris Presents Data Highlighting the Potential for Deucrictibant to Prevent and Treat Bradykinin-Mediated Angioedema Attacks at the EAACI Congress
-
VEON Announces USD 35 Million Share Buyback
-
Castellum Announces Closing of $5.0 Million Public Offering of Common Stock and Warrants
-
Blue Moon Metals Completes First Blast on Nussir Access Portal Ahead of Schedule
-
AirSculpt Strengthens Balance Sheet with $10.0 Million Debt Paydown
-
Subsea 7 S.A. - 2Q25 earnings call notification
-
Exploring Changzhou's Life Aesthetics Along Grand Canal
-
Exploring Changzhou's Life Aesthetics Along Grand Canal
-
Inflection Resources to Acquire Portfolio of Australian Copper-Gold Projects from Newmont Corporation
-
Second Drill Hole at Potro SE Extends Polymetallic Mineralization at Mirasol’s Flagship Sobek Gold-Silver-Copper Project in the Vicuña District, Chile
-
Net Asset Value(s)
